Lee Kim Swee

Lee Kim Swee has a diverse work experience in the biotechnology and pharmaceutical industry. Starting in 2003, Lee worked as a Master student at the Institute of Biochemistry, University of Lausanne. In 2004, Lee joined the University of Basel as a PhD student, where they worked until 2008.

In 2010, Lee joined Scil Technology GmbH as a Scientist and later that year moved to the Whitehead Institute as a Postdoctoral Fellow, a position they held until 2014. During this time, Lee's research focused on biology and laboratory work.

From 2014 to 2018, Lee worked as a Research Group Leader at the BioMed X Institute, gaining experience in leading and managing research projects. In 2018, Lee joined Boehringer Ingelheim as a Principal Scientist and Head of Laboratory, where they worked until 2021. In 2021, Lee was promoted to the role of Senior Principal Scientist before leaving the company.

Currently, Lee is working at Odyssey Therapeutics as the Director of Biology, a role they started in January 2022.

Lee Kim Swee attended the University of Lausanne - UNIL but did not complete a degree or specify a field of study or dates of attendance.